Lisata Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update


Encouraging results of Cohort A data from the ASCEND trial presented at ASCO-GI 2025;Cohort B results from the ASCEND trial accepted for an oral presentation at ESMO-GI 2025

Go here to see the original:
Lisata Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

Related Posts